CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
49 hedge funds and large institutions have $52.1M invested in Crescent Biopharma, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 11 closing their positions.
Holders
49
Holders Change
-6
Holders Change %
-10.91%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
18
Closed
11
Calls
$389K
Puts
$31K
Net Calls
+$358K
Net Calls Change
+$231K